News

Antipsychotics’ risk in dementia revised upward


 

AT THE AAGP ANNUAL MEETING

Dr. Maust’s study was sponsored by the National Institute of Mental Health and the University of Michigan Program for Positive Aging. He reported having no financial conflicts, as did Dr. Lee, whose study was unfunded.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Pseudobulbar affect: More common than you’d think
MDedge Family Medicine
USPSTF: Evidence still ‘insufficient’ to back cognitive impairment screening
MDedge Family Medicine
Hoarding: Not just a symptom of OCD
MDedge Family Medicine
Late-life depression can be dementia prodrome
MDedge Family Medicine
Say goodbye to ‘dementia’
MDedge Family Medicine
ECT quells dementia-associated agitation
MDedge Family Medicine
Autism starts in utero, brain tissue study indicates
MDedge Family Medicine
Simple smell test may predict donepezil response
MDedge Family Medicine
Human brain mapping project begins to reveal roots of developmental abnormalities
MDedge Family Medicine
Depression at least five times more common than PTSD after critical illness
MDedge Family Medicine